KOJINTX Trademark

Trademark Overview

On Wednesday, May 1, 2024, a trademark application was filed for KOJINTX with the United States Patent and Trademark Office. The USPTO has given the KOJINTX trademark a serial number of 98528844. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, May 1, 2024. This trademark is owned by Kojin Therapeutics, Inc.. The KOJINTX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development of therapeutics for the treatment of cancer, asthma and inflammatory diseases, autoimmune diseases, cardiovascular diseases, liver diseases, degenerative diseases, infectious diseases, allergies, central nervous system diseases, and renal diseases; providing scientific research information in the field of therapeutics for the treatment of cancer, asthma and inflammatory diseases, autoimmune diseases, cardiovascular diseases, liver diseases, degenerative diseases, infectious diseases, allergies, central nervous system diseases, and renal diseases
kojintx

General Information

Serial Number98528844
Word MarkKOJINTX
Filing DateWednesday, May 1, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, May 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the word "Kojin" together with the letters "TX" in superscript, all in white on an orange background..
Indication of Colors claimedThe color(s) orange and white is/are claimed as a feature of the mark.
Goods and Servicesresearch and development of therapeutics for the treatment of cancer, asthma and inflammatory diseases, autoimmune diseases, cardiovascular diseases, liver diseases, degenerative diseases, infectious diseases, allergies, central nervous system diseases, and renal diseases; providing scientific research information in the field of therapeutics for the treatment of cancer, asthma and inflammatory diseases, autoimmune diseases, cardiovascular diseases, liver diseases, degenerative diseases, infectious diseases, allergies, central nervous system diseases, and renal diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 1, 2024
Primary Code042
First Use Anywhere DateSunday, May 31, 2020
First Use In Commerce DateWednesday, September 30, 2020

Trademark Owner History

Party NameKojin Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Wednesday, May 1, 2024NEW APPLICATION ENTERED

Related Keywords

kojintx diseases infectious degenerative allergies central renal system nervous research liver